Alumni

Main navigation

Genetic sequencing project receives more than $8 million in funding

Published: 18 March 2025

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians...

Read more about Genetic sequencing project receives more than $8 million in funding

Prescribing anti-swelling drug reduces immune response weeks after last dose

Published: 26 February 2025

Mapping immune cell diversity reveals dexamethasone’s impact on brain cancer immunotherapy...

Read more about Prescribing anti-swelling drug reduces immune response weeks after last dose

An open solution to improving research reproducibility

Published: 18 December 2024

Academic and industry scientists collaborate on a new method to characterize research antibodies

Read more about An open solution to improving research reproducibility

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Published: 25 March 2025

Free, online training program strengthens training and brings specialized care to communities across Quebec...

Read more about Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

Six principal investigators from The Neuro receive CIHR grants

Published: 10 February 2025

Projects include important research on Parkinson’s, glioblastoma and dementia

Read more about Six principal investigators from The Neuro receive CIHR grants

2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

Thursday, November 13, 2025 16:00to17:00

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the...

Read more about 2025 Hughlings Jackson Lecture: The Basal Ganglia and the Motivation to Act

D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Published: 26 March 2025

Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...